603127 Stock Overview
Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Joinn Laboratories(China)Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.84 |
| 52 Week High | CN¥27.34 |
| 52 Week Low | CN¥12.32 |
| Beta | 0.66 |
| 11 Month Change | 8.46% |
| 3 Month Change | 42.94% |
| 1 Year Change | -30.61% |
| 33 Year Change | -73.37% |
| 5 Year Change | 24.40% |
| Change since IPO | 687.65% |
Recent News & Updates
Recent updates
Joinn Laboratories(China)Co.,Ltd.'s (SHSE:603127) 28% Share Price Surge Not Quite Adding Up
Oct 01
Joinn Laboratories(China)Co.,Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Sep 03Joinn Laboratories(China)Co.Ltd (SHSE:603127) Is Reducing Its Dividend To CN¥0.16
Jul 28Joinn Laboratories(China)Co.,Ltd. (SHSE:603127) Analysts Just Cut Their EPS Forecasts Substantially
Apr 08There May Be Reason For Hope In Joinn Laboratories(China)Co.Ltd's (SHSE:603127) Disappointing Earnings
Apr 04Shareholder Returns
| 603127 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 2.1% | -5.5% | -3.4% |
| 1Y | -30.6% | -28.5% | 6.1% |
Return vs Industry: 603127 underperformed the CN Life Sciences industry which returned -28.5% over the past year.
Return vs Market: 603127 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 603127 volatility | |
|---|---|
| 603127 Average Weekly Movement | 8.6% |
| Life Sciences Industry Average Movement | 10.3% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 603127 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603127's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 2,585 | Dapeng Gao | www.joinn-lab.com |
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models.
Joinn Laboratories(China)Co.,Ltd. Fundamentals Summary
| 603127 fundamental statistics | |
|---|---|
| Market cap | CN¥12.81b |
| Earnings (TTM) | -CN¥912.86k |
| Revenue (TTM) | CN¥2.12b |
6.5x
P/S Ratio9,999x
P/E RatioIs 603127 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603127 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.12b |
| Cost of Revenue | CN¥1.47b |
| Gross Profit | CN¥653.83m |
| Other Expenses | CN¥654.75m |
| Earnings | -CN¥912.86k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0012 |
| Gross Margin | 30.78% |
| Net Profit Margin | -0.043% |
| Debt/Equity Ratio | 0% |
How did 603127 perform over the long term?
See historical performance and comparison